The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Affective Symptoms

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Affective Symptoms

 

Psychiatry related information on Affective Symptoms

 

High impact information on Affective Symptoms

  • The status of the serotonin receptor system may affect the reproductive capacity of an organism and may be related to sex-linked emotional disturbances in humans [11].
  • The Great Smoky Mountains Study of Youth. Functional impairment and serious emotional disturbance [12].
  • Lithium carbonate benefit did not seem to be restricted to affective symptoms only [13].
  • RESULTS: Men with alexithymia demonstrated less cerebral activation in the left mediofrontal-paracingulate cortex in response to highly negative stimuli and more activation in the anterior cingulate, mediofrontal cortex, and middle frontal gyrus in response to highly positive stimuli than men without alexithymia [14].
  • Greater reductions in severity of positive and affective symptoms were seen with risperidone than with olanzapine treatment among study completers [15].
 

Chemical compound and disease context of Affective Symptoms

  • Furthermore, in a group of smokers with a history of major depression, affective symptoms, without concurrent syndromal illness, may be ameliorated by treatment with fluoxetine [16].
  • Bipolar affective symptoms associated with use of captopril and abrupt withdrawal of pargyline and propranolol [17].
  • Quetiapine is superior to placebo and at least equivalent to haloperidol for improving a broad range of symptoms encountered in patients with schizophrenia, including positive symptoms, negative symptoms, affective symptoms, and cognitive outcomes [18].
  • The symptom of "diminished interest or pleasure" in rewarding stimuli is an affective symptom of nicotine and amphetamine withdrawal, and a core symptom of depression [19].
  • In preclinical studies, ziprasidone was predicted to have efficacy against positive, negative and affective symptoms of schizophrenia with a favourable tolerability profile, including a low propensity to induce extrapyramidal adverse effects [20].
 

Biological context of Affective Symptoms

 

Anatomical context of Affective Symptoms

 

Gene context of Affective Symptoms

  • We therefore investigated in healthy women the relationship between alexithymia and circulating levels of IL-1, IL-2 and IL-4 [29].
  • We therefore investigated in healthy women the relationship between alexithymia and circulating levels of IL-1, IL-2 and IL-4 [30].
  • To assess seasonal affective symptoms in adults with ADHD, 115 individuals attending an adult ADHD clinic in Toronto, Ontario, Canada were asked to complete the Seasonal Pattern Assessment Questionnaire (SPAQ) [31].
  • We investigated the relationship between COMT Val108/158Met, serotonin transporter coding sequence (5-HT transporter gene-linked polymorphic region; 5-HTTLPR) polymorphisms, and alexithymia.The study sample comprised 109 students at the Korea University. All participants were tested using the 20-item Toronto Alexithymia Scale (TAS-20) [26].
  • Reductions in 5-HT1A binding in the insula and cingulate suggest a mechanism by which affective symptoms in MTLE may result [28].
 

Analytical, diagnostic and therapeutic context of Affective Symptoms

References

  1. Effect of sodium valproate in three patients with organic brain syndromes. Kahn, D., Stevenson, E., Douglas, C.J. The American journal of psychiatry. (1988) [Pubmed]
  2. Treatment of bulimia and rapid-cycling bipolar disorder with sodium valproate: a case report. Herridge, P.L., Pope, H.G. Journal of clinical psychopharmacology. (1985) [Pubmed]
  3. Site-specific activation of dopamine and serotonin transmission by aniracetam in the mesocorticolimbic pathway of rats. Nakamura, K., Shirane, M., Koshikawa, N. Brain Res. (2001) [Pubmed]
  4. Psychological aspects of dietary weight loss and medication with the atypical beta agonist BRL 26830A in obese subjects. MacLachlan, M., Connacher, A.A., Jung, R.T. International journal of obesity. (1991) [Pubmed]
  5. Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington's disease. Scattoni, M.L., Valanzano, A., Popoli, P., Pezzola, A., Reggio, R., Calamandrei, G. Behav. Brain Res. (2004) [Pubmed]
  6. Effectiveness of lithium in schizophrenia: do we really have an answer? Atre-Vaidya, N., Taylor, M.A. The Journal of clinical psychiatry. (1989) [Pubmed]
  7. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease. Raskind, M.A. The Journal of clinical psychiatry. (1998) [Pubmed]
  8. Long-term administration of valproic acid in the treatment of affective symptoms in people with mental retardation. Kastner, T., Finesmith, R., Walsh, K. Journal of clinical psychopharmacology. (1993) [Pubmed]
  9. Alexithymia is associated with low tolerance to experimental painful stimulation. Nyklícek, I., Vingerhoets, A.J. Pain (2000) [Pubmed]
  10. Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial. Keck, P., Buffenstein, A., Ferguson, J., Feighner, J., Jaffe, W., Harrigan, E.P., Morrissey, M.R. Psychopharmacology (Berl.) (1998) [Pubmed]
  11. Sex differences in serotonin 1 receptor binding in rat brain. Fischette, C.T., Biegon, A., McEwen, B.S. Science (1983) [Pubmed]
  12. The Great Smoky Mountains Study of Youth. Functional impairment and serious emotional disturbance. Costello, E.J., Angold, A., Burns, B.J., Erkanli, A., Stangl, D.K., Tweed, D.L. Arch. Gen. Psychiatry (1996) [Pubmed]
  13. Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study. Biederman, J., Lerner, Y., Belmaker, R.H. Arch. Gen. Psychiatry (1979) [Pubmed]
  14. Effect of impaired recognition and expression of emotions on frontocingulate cortices: an fMRI study of men with alexithymia. Berthoz, S., Artiges, E., Van De Moortele, P.F., Poline, J.B., Rouquette, S., Consoli, S.M., Martinot, J.L. The American journal of psychiatry. (2002) [Pubmed]
  15. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. Conley, R.R., Mahmoud, R. The American journal of psychiatry. (2001) [Pubmed]
  16. Mood, major depression, and fluoxetine response in cigarette smokers. Dalack, G.W., Glassman, A.H., Rivelli, S., Covey, L., Stetner, F. The American journal of psychiatry. (1995) [Pubmed]
  17. Bipolar affective symptoms associated with use of captopril and abrupt withdrawal of pargyline and propranolol. McMahon, T. The American journal of psychiatry. (1985) [Pubmed]
  18. Improvement without impairment: a review of clinical data for quetiapine in the treatment of schizophrenia. Tandon, R. Journal of clinical psychopharmacology. (2003) [Pubmed]
  19. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Harrison, A.A., Liem, Y.T., Markou, A. Neuropsychopharmacology (2001) [Pubmed]
  20. Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder. Gunasekara, N.S., Spencer, C.M., Keating, G.M. Drugs (2002) [Pubmed]
  21. Modulation by estradiol of serotonin receptors in brain. Biegon, A., McEwen, B.S. J. Neurosci. (1982) [Pubmed]
  22. Is there a clinical relevance of partial androgen deficiency of the aging male? Christ-Crain, M., Mueller, B., Gasser, T.C., Kraenzlin, M., Trummler, M., Huber, P., Meier, C. J. Urol. (2004) [Pubmed]
  23. Menstrual cycle and appetite control: implications for weight regulation. Dye, L., Blundell, J.E. Hum. Reprod. (1997) [Pubmed]
  24. Diurnal rhythm in extracellular levels of 5-hydroxyindoleacetic acid in the medial prefrontal cortex of freely moving rats: an in vivo microdialysis study. Nakayama, K. Prog. Neuropsychopharmacol. Biol. Psychiatry (2002) [Pubmed]
  25. Perimenopausal hormone replacement therapy. Review of the literature. Lichtman, R. Journal of nurse-midwifery. (1991) [Pubmed]
  26. Association between the catechol O-methyltransferase Val108/158Met polymorphism and alexithymia. Ham, B.J., Lee, M.S., Lee, Y.M., Kim, M.K., Choi, M.J., Oh, K.S., Jung, H.Y., Lyoo, I.K., Choi, I.G. Neuropsychobiology (2005) [Pubmed]
  27. A longitudinal study of low back pain in student nurses. Klaber Moffett, J.A., Hughes, G.I., Griffiths, P. International journal of nursing studies. (1993) [Pubmed]
  28. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Savic, I., Lindström, P., Gulyás, B., Halldin, C., Andrée, B., Farde, L. Neurology (2004) [Pubmed]
  29. Correlation between serum levels of interleukin-4 and alexithymia scores in healthy female subjects: preliminary findings. Corcos, M., Guilbaud, O., Paterniti, S., Curt, F., Hjalmarsson, L., Moussa, M., Chambry, J., Loas, G., Chaouat, G., Jeammet, P. Psychoneuroendocrinology (2004) [Pubmed]
  30. Correlation between serum levels of interleukin-4 and alexithymia scores in healthy female subjects: preliminary findings. Corcos, M., Guilbaud, O., Paterniti, S., Curt, F., Hjalmarsson, L., Moussa, M., Chambry, J., Loas, G., Chaouat, G., Jeammet, P. Psychoneuroendocrinology (2004) [Pubmed]
  31. Seasonal affective symptoms in adults with residual attention-deficit hyperactivity disorder. Levitan, R.D., Jain, U.R., Katzman, M.A. Comprehensive psychiatry. (1999) [Pubmed]
  32. Association between pretransplant psychological assessments and posttransplant psychiatric disorders in living-related transplantation. Fukunishi, I., Sugawara, Y., Takayama, T., Makuuchi, M., Kawarasaki, H., Surman, O.S. Psychosomatics. (2002) [Pubmed]
  33. Possible therapeutic effect of T-794, a novel reversible inhibitor of monoamine oxidase-A, on post-stroke emotional disturbances, assessed in animal models of depression. Kato, M., Iwata, H., Katayama, T., Asai, H., Narita, H., Endo, T. Biol. Pharm. Bull. (1997) [Pubmed]
  34. Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. Sandyk, R., Awerbuch, G.I. Int. J. Neurosci. (1993) [Pubmed]
 
WikiGenes - Universities